Kevin Sidow is Director at CARLSMED, INC. (CARL). They have made 1 open-market trade across 1 company since 2025, most recently 2026-06-03.
CIK 0001416947
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $200K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CARL | 73,264 | $985K |
Shares reported on the most recent Form 4, priced at the 2026-06-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARL | BUY | 2025-07-24 | 2025-07-24 | $15.00 | $200K | -16.7% | -2.4% | -5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.